INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% ...

The Calibr-Skaggs Institute for Innovative Medicines , the drug development division of Scripps Research, today announced a milestone in ...

Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

ABOUT ORPHAN DRUG DESIGNATION The FDA grants Orphan Drug Designation to investigational drugs intended for the treatment of rare diseases affecting fewer than 200,000 people in the U.S. Benefits ...

The firm is developing the PHOX2B-targeted cell therapy, which has shown promise in preclinical xenograft models, with CHOP researchers.

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...

Mayo Clinic Jacksonville (Fla.) opened a $320 million cancer center, which will house first carbon ion therapy program in the the Americas. The 228,000-square-foot Duan Family Building opened June 11, ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

Mr Sherry added his wife had told him: "No mammy should have to be away from their children." He has called for a more joined ...

I’m working to make cancer treatments less painful by developing donor-derived CAR therapies, so others don’t have to suffer ...

Adding polatuzumab vedotin to rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved overall survival in transplant-ineligible patients with relapsed/refractory diffuse large B-cell ...